Healthcare
Infarmed prohibits the export of 52 medicines
The health authority Infarmed has suspended the export of 52 medicines, including certain antidepressants, painkillers, antibiotics, and cancer treatments, effective Tuesday, 2026-10-06. The list also includes 163 presentations of quetiapine, an antipsychotic, due to supply constraints caused by a microbial contamination at a manufacturing site in Greece; these shortages are expected to persist until the end of the year.
Why it mattersIf you rely on specific medications, particularly quetiapine or common antibiotics and antidepressants, be aware that supply issues linked to this manufacturing shutdown are expected to continue through the end of 2026, which may affect local pharmacy stock.
Correio da Manhã
